Comparison of efficacy of low-volume bowel cleansers prior to colonoscopy: a randomised, prospective, open-label trial

Rozhl Chir. 2019 Summer;98(7):277-281.

Abstract

Introduction: The aim of the study was to compare the efficacy and tolerability of polyethylene glycol/ascorbic acid (PEGA), sodium picosulfate/magnesium citrate (SPMC) and the oral sulfate formula (SIR) in a single- or split-dose regimen for bowel preparation prior to colonoscopy.

Methods: Randomised, multicentre, open-label study. The subjects received either PEGA, SPMC or SIR in the single- or split-dose regimen before the colonoscopy. Quality and tolerability of the preparation and complaints during preparation were recorded using a 5 point scale.

Results: 558 subject were analysed. Preparation quality was comparable in the single-dose regimen. The rate of satisfactory bowel cleansing (Aronchick score 1+2) was higher for split-dose SIR and PEGA compared to SPMC (95.6%, 86.2% vs. 72.5%, p.

Keywords: ascorbic acid; colonoscopy; picosulfate; polyethylene glycol; sulfates.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Ascorbic Acid* / therapeutic use
  • Cathartics* / therapeutic use
  • Colonoscopy*
  • Humans
  • Polyethylene Glycols* / therapeutic use
  • Prospective Studies

Substances

  • Cathartics
  • Polyethylene Glycols
  • Ascorbic Acid